Skip to main content

Table 1 The comparative pre- operative data from the patients both groups.

From: Perioperative infusion of low- dose of vasopressin for prevention and management of vasodilatory vasoplegic syndrome in patients undergoing coronary artery bypass grafting-A double-blind randomized study

 

Group A

Group B

p

General characteristics

Number of patients

25

25

-

Male/female

20/5

21/4

1

Age (y/s)

66 ± 13

62 ± 15

0,319

Height (cm)

164 ± 9

168 ± 11

0,166

Weight (kg)

75 ± 11

72 ± 8

0,276

BSA

1.74 ± 7.4

1.82 ± 6.6

0,968

Clinical preoperative data

Hypertension

16

14

0.773

Diabetes mellitus

8

10

0.769

Euroscore

4.8 ± 2.2

4.5 ± 2.6

0,662

3-coronary vessel disease

19

17

0.754

2-coronary vessel disease

6

9

0.538

Significant Left main CAD

2

4

0.667

Ischemic mitral regurgitation 1+/4+

7

4

0.496

Ischemic mitral regurgitation 2+/4+

4

8

0.321

Ejection fraction 30-35%

9

12

0.567

Ejection fraction 35-40%

16

13

0.567

Cardiac Index (L/min/m 2 )

3.1 ± 0,6

3.2 ± 0.8

0,619

PCWP < 15

9

10

0.773

PCWP > 15

16

15

0.773

Preoperative medication

aMEA

25

25

-

b-blockers

14

17

0.377

Calcium channel blockers (pts)

11

8

0.561